InsiderTrades

Form 4 for DXCM Dexcom

Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001093557-23-000139 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
I 2023-05-22 2023-05-18 DXCM FOLETTA MARK G Dir G - Gift $0.00 +4,488 59.1K +8% $0
2023-05-22 2023-05-18 DXCM FOLETTA MARK G Dir G - Gift $0.00 -4,488 3,306 -58% $0
2023-05-22 2023-05-18 DXCM FOLETTA MARK G Dir A - Grant $0.00 +3,306 7,794 +74% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-18 G A 4,488 $0.00 59,092 I — — (F2) Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units. (F3) Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.
2 Common Common Stock 2023-05-18 G D 4,488 $0.00 3,306 D — — (F2) Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units.
3 Common Common Stock 2023-05-18 A A 3,306 $0.00 7,794 D by Trust — — (F1) The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.